Knauer, Shirley; Krämer, Oliver H.; Knösel, Thomas; Engels, Knut; Rödel, Franz; Kovács, Adorján F.; Dietmaier, Wolfgang; Klein-Hitpaß, Ludger; Habtemichael, Negusse; Schweitzer, Andrea; Brieger, Jürgen; Rödel, Claus; Mann, Wolf; Petersen, Iver; Heinzel, Thorsten; Stauber, Roland H. et al:
Nuclear export is essential for the tumor-promoting activity of survivin
In: The FASEB Journal : the official journal of the Federation of American Societies for Experimental Biology, Jg. 21 (2007), Heft 1, S. 207 - 216
2007Artikel/Aufsatz in Zeitschrift
Biologie
Titel in Englisch:
Nuclear export is essential for the tumor-promoting activity of survivin
Autor*in:
Knauer, ShirleyUDE
LSF ID
51606
ORCID
0000-0003-4321-0924ORCID iD
Sonstiges
der Hochschule zugeordnete*r Autor*in
;
Krämer, Oliver H.;Knösel, Thomas;Engels, Knut;Rödel, Franz;Kovács, Adorján F.;Dietmaier, Wolfgang;Klein-Hitpaß, LudgerUDE
LSF ID
14385
ORCID
0000-0002-6406-8376ORCID iD
Sonstiges
der Hochschule zugeordnete*r Autor*in
;
Habtemichael, Negusse;Schweitzer, Andrea;Brieger, Jürgen;Rödel, Claus;Mann, Wolf;Petersen, Iver;Heinzel, Thorsten;Stauber, Roland H.
Erscheinungsjahr:
2007

Abstract in Englisch:

Survivin appears to function as an apoptosis inhibitor and a regulator of cell division during development and tumorigenesis. Here we report the molecular characterization of the nucleocytoplasmic transport of survivin and its potential implications for tumorigenesis. We identified an evolutionary conserved Crm1-dependent nuclear export signal (NES) in survivin. In dividing cells, the NES is essential for tethering survivin and the survivin/Aurora-B kinase complex to the mitotic machinery, which in turn appears to be essential for proper cell division. In addition, export seems to be required for the cytoprotective activity of survivin, as export-deficient survivin fails to protect tumor cells against chemo- and radiotherapy-induced apoptosis. These findings appear to be clinically relevant since preferential nuclear localization of survivin correlated with enhanced survival in colorectal cancer patients. Targeting survivin’s nuclear export by the application of NES-specific antibodies promoted its nuclear accumulation and inhibited its cytoprotective function. We demonstrate that nuclear export is essential for the biological activity of survivin and promote the identification of molecular decoys to specifically interfere with survivin’s nuclear export as potential anticancer therapeutics.